Skip to content
healthcare.dev

Second Chakra (Sacral) 7302

NDC 63083-7302, Second Chakra (Sacral), liquid, from Professional Complementary Health Formulas.

Product NDC
63083-7302
Status
Listed
Labeler
Professional Complementary Health Formulas
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63083-7302 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HELLEBORUS NIGER ROOT8 [hp_X]/29.5mL
  • STRYCHNOS IGNATII SEED8 [hp_X]/29.5mL
  • POTASSIUM CHLORATE8 [hp_X]/29.5mL
  • MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE8 [hp_X]/29.5mL
  • ARTEMISIA CINA PRE-FLOWERING TOP10 [hp_X]/29.5mL
  • BOS TAURUS BILE12 [hp_X]/29.5mL
  • LACHESIS MUTA VENOM12 [hp_X]/29.5mL
  • SEPIA OFFICINALIS JUICE12 [hp_X]/29.5mL
  • SILICON DIOXIDE30 [hp_X]/29.5mL

Pharmacologic classes

Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
63083-7302-16308373020129.5 mL in 1 BOTTLE, DROPPER (63083-7302-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63083-7302 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63083-7302 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63083-7302. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.